134 related articles for article (PubMed ID: 15668495)
1. Effects of false-positive prostate cancer screening results on subsequent prostate cancer screening behavior.
Ford ME; Havstad SL; Demers R; Cole Johnson C
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):190-4. PubMed ID: 15668495
[TBL] [Abstract][Full Text] [Related]
2. Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men.
Woods VD; Montgomery SB; Herring RP; Gardner RW; Stokols D
J Natl Med Assoc; 2006 Apr; 98(4):492-504. PubMed ID: 16623061
[TBL] [Abstract][Full Text] [Related]
3. Preparing African-American men in community primary care practices to decide whether or not to have prostate cancer screening.
Myers RE; Daskalakis C; Cocroft J; Kunkel EJ; Delmoor E; Liberatore M; Nydick RL; Brown ER; Gay RN; Powell T; Powell RL
J Natl Med Assoc; 2005 Aug; 97(8):1143-54. PubMed ID: 16173330
[TBL] [Abstract][Full Text] [Related]
4. Implications of false-positive results for future cancer screenings.
Taksler GB; Keating NL; Rothberg MB
Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
[TBL] [Abstract][Full Text] [Related]
5. The Effectiveness of Shared Compared to Informed Decision Making for Prostate Cancer Screening in a High-Risk African American Population: A Randomized Control Trial.
Carlson DS; Grivas P; Wei W; Dhillon PK; Abraksia S
Cancer Invest; 2021 Feb; 39(2):124-132. PubMed ID: 33410359
[TBL] [Abstract][Full Text] [Related]
6. Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial.
Miller EA; Pinsky PF; Black A; Andriole GL; Pierre-Victor D
Prostate; 2018 Aug; 78(11):830-838. PubMed ID: 29667217
[TBL] [Abstract][Full Text] [Related]
7. African American Women's Involvement in Promoting Informed Decision-Making for Prostate Cancer Screening Among Their Partners/Spouses.
Allen JD; Akinyemi IC; Reich A; Fleary S; Tendulkar S; Lamour N
Am J Mens Health; 2018 Jul; 12(4):884-893. PubMed ID: 29298558
[TBL] [Abstract][Full Text] [Related]
8. Use of Digital Rectal Examination as an Adjunct to Prostate Specific Antigen in the Detection of Clinically Significant Prostate Cancer.
Halpern JA; Oromendia C; Shoag JE; Mittal S; Cosiano MF; Ballman KV; Vickers AJ; Hu JC
J Urol; 2018 Apr; 199(4):947-953. PubMed ID: 29061540
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer screening in high-risk men: African American Hereditary Prostate Cancer Study Network.
Weinrich SP
Cancer; 2006 Feb; 106(4):796-803. PubMed ID: 16411222
[TBL] [Abstract][Full Text] [Related]
10. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
[TBL] [Abstract][Full Text] [Related]
11. Racial differences in operating characteristics of prostate cancer screening tests.
Smith DS; Bullock AD; Catalona WJ
J Urol; 1997 Nov; 158(5):1861-5; discussion 1865-6. PubMed ID: 9334618
[TBL] [Abstract][Full Text] [Related]
12. Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making.
Woods-Burnham L; Stiel L; Wilson C; Montgomery S; Durán AM; Ruckle HR; Thompson RA; De León M; Casiano CA
Am J Mens Health; 2018 Jul; 12(4):751-759. PubMed ID: 29658371
[TBL] [Abstract][Full Text] [Related]
13. Men's knowledge and beliefs about prostate cancer: education, race, and screening status.
Winterich JA; Grzywacz JG; Quandt SA; Clark PE; Miller DP; Acuña J; Dignan MB; Arcury TA
Ethn Dis; 2009; 19(2):199-203. PubMed ID: 19537233
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm.
Halpern JA; Shoag JE; Mittal S; Oromendia C; Ballman KV; Hershman DL; Wright JD; Shih YT; Nguyen PL; Hu JC
J Urol; 2017 Feb; 197(2):363-368. PubMed ID: 27569432
[TBL] [Abstract][Full Text] [Related]
15. Screening for prostate cancer.
Ilic D; Neuberger MM; Djulbegovic M; Dahm P
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
[TBL] [Abstract][Full Text] [Related]
16. Preparing African American Men to Make Informed Prostate Cancer Screening Decisions: Development and Pilot Testing of an Interactive Online Decision Aid.
Allen JD; Reich A; Cuevas AG; Ladin K
JMIR Mhealth Uhealth; 2020 May; 8(5):e15502. PubMed ID: 32369032
[TBL] [Abstract][Full Text] [Related]
17. Racial Disparities in Prostate Cancer Screening: The Role of Shared Decision Making.
Frego N; Beatrici E; Labban M; Stone BV; Filipas DK; Koelker M; Lughezzani G; Buffi NM; Osman NY; Lipsitz SR; Sammon JD; Kibel AS; Trinh QD; Cole AP
Am J Prev Med; 2024 Jan; 66(1):27-36. PubMed ID: 37567369
[TBL] [Abstract][Full Text] [Related]
18. Five-year downstream outcomes following prostate-specific antigen screening in older men.
Walter LC; Fung KZ; Kirby KA; Shi Y; Espaldon R; O'Brien S; Freedland SJ; Powell AA; Hoffman RM
JAMA Intern Med; 2013 May; 173(10):866-73. PubMed ID: 23588999
[TBL] [Abstract][Full Text] [Related]
19. Determinants of Prostate Specific Antigen Screening among Black Men in the United States in the Contemporary Era.
Sammon JD; Dalela D; Abdollah F; Choueiri TK; Han PK; Hansen M; Nguyen PL; Sood A; Menon M; Trinh QD
J Urol; 2016 Apr; 195(4 Pt 1):913-8. PubMed ID: 26598427
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies.
Shelton JB; Barocas DA; Conway F; Hart K; Nelson K; Richstone L; Gonzalez RR; Raman JD; Scherr DS
Urology; 2005 May; 65(5):931-6. PubMed ID: 15882726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
